Why Investors Are Voting Against Novo Nordisk
Motley Fool
5 Companies Dominating Diabetes
Motley Fool
Novo hikes forecast on 62% jump in Victoza sales
Fierce Pharma
Novo Nordisk says FDA disclosed focus of upcoming panel meeting
The Fly on the Wall
Novo Nordisk: Encouraging Pipeline News
Seeking Alpha

